umbilical cord-derived mesenchymal stem cells (Shandong Qilu Cell Therapy Engineering Technology/Shandong Public Health Clinical Center)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Nameumbilical cord-derived mesenchymal stem cells (Shandong Qilu Cell Therapy Engineering Technology/Shandong Public Health Clinical Center)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Stem cell therapy > Umbilical cord stem cell therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsAcquired Immunodeficiency SyndromeHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesGeneral Inception
China Registration ClassN/A

Develop Information

Active CompaniesGeneral InceptionShandong Public Health Clinical Center
Inactive CompaniesN/A
Active IndicationsAcquired Immunodeficiency SyndromeHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A